ArticleJournal of atherosclerosis and thrombosis2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.
Tomoko Otsuki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.